Health Care

Commentary

Rush Job

Doctors and students unite against socialized medicine. An NRO Q&A Tonight in New York City, the Benjamin Rush Society will host its inaugural event: a debate on health care before a gathering of medical students and doctors. Under the leadership of Sally C. Pipes, president and CEO of the Pacific ...
Commentary

Two ways to look at health care

U.S. Rep. Chris Murphy, D-5th District, had a captive audience Monday. During a meeting with New Britain business leaders, Peter Knaus, a builder in the city, wanted to understand why the Obama Administration believes we can’t get the economy back on track without first fixing the health-care system. “I understand ...
Business & Economics

Putting Drug Research in Legal Jeopardy

The U.S. Supreme Court’s recent ruling in Wyeth v. Levine—holding that drug manufacturers are not free of liability under state law, even when the drug in question has secured federal regulatory approval—has worried pharmaceutical manufacturers, who can now face crippling state tort lawsuits despite being in regulatory compliance. A less-noticed ...
Business & Economics

For the Love of the Game

The 2009 Major League Baseball season starts on Sunday night, when the Atlanta Braves visit the Philadelphia Phillies. On Monday, 13 more clubs will host their Opening Day games. We asked a distinguished group of fans — one for each of MLB’s 30 teams — to account for their passion. ...
Commentary

Conservative Alliance Outlines 6 Deal-Killers for National Health Reform

Washington, April 1, 2009 –Medical costs are rising too fast, the quality of service is uneven and too many people have difficulty getting or keeping insurance coverage. Both left and right agree on the need to reform the American health care system. But not all agree on the best way ...
Commentary

Would the Health Reform Prescriptions Offered by President Obama and Congressional Leaders Help Patients?

Health Policy Consensus Group Statement By Thomas P. Miller, Scott Gottlieb, M.D., Robert B. Helms, Joseph Antos, Doug Badger, Robert A. Book, James C. Capretta, Greg D’Angelo, Stephen J. Entin, John C. Goodman, Linda Gorman, John R. Graham, Paul Guppy, John S. Hoff, Merrill Matthews, Amy Menefee, Robert E. Moffit, ...
Commentary

JAMA Wants to Restrict Competition for Pharma Dollars

Many elite, academic doctors would like to believe that they can create a world where human beings do not influence other human beings. This makes them ashamed of their profession’s relationship with research-based drug companies. They believe that any item or communication from a … more »»
Commentary

The “Congressional” Health Care Plan

With the highly publicized White House Forum on Health Reform now in the rearview mirror, President Obama has taken his show on the road. The administration is in the midst of holding five other such forums across the country. These gatherings are intended to set the stage for congressional action ...
Commentary

Leviathan’s Drug Problem: Federal Monopoly of Pharmaceutical Regulation and its Deadly Cost

A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration’s performance and concludes that the agency is overfunded, overstaffed, and denies hundreds of thousands of Americans timely access to new medicines. Leviathan’ s Drug Problem: The Cost of the Federal Monopoly ...
Commentary

FDA is Overfunded, Overstaffed, and Costs Lives According to New Pacific Research Institute Report

FDA is Overfunded, Overstaffed, and Costs Lives According to New Pacific Research Institute Report San Francisco (March 20, 2009) — A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration’s performance and concludes that the agency is overfunded, overstaffed, and denies ...
Commentary

Rush Job

Doctors and students unite against socialized medicine. An NRO Q&A Tonight in New York City, the Benjamin Rush Society will host its inaugural event: a debate on health care before a gathering of medical students and doctors. Under the leadership of Sally C. Pipes, president and CEO of the Pacific ...
Commentary

Two ways to look at health care

U.S. Rep. Chris Murphy, D-5th District, had a captive audience Monday. During a meeting with New Britain business leaders, Peter Knaus, a builder in the city, wanted to understand why the Obama Administration believes we can’t get the economy back on track without first fixing the health-care system. “I understand ...
Business & Economics

Putting Drug Research in Legal Jeopardy

The U.S. Supreme Court’s recent ruling in Wyeth v. Levine—holding that drug manufacturers are not free of liability under state law, even when the drug in question has secured federal regulatory approval—has worried pharmaceutical manufacturers, who can now face crippling state tort lawsuits despite being in regulatory compliance. A less-noticed ...
Business & Economics

For the Love of the Game

The 2009 Major League Baseball season starts on Sunday night, when the Atlanta Braves visit the Philadelphia Phillies. On Monday, 13 more clubs will host their Opening Day games. We asked a distinguished group of fans — one for each of MLB’s 30 teams — to account for their passion. ...
Commentary

Conservative Alliance Outlines 6 Deal-Killers for National Health Reform

Washington, April 1, 2009 –Medical costs are rising too fast, the quality of service is uneven and too many people have difficulty getting or keeping insurance coverage. Both left and right agree on the need to reform the American health care system. But not all agree on the best way ...
Commentary

Would the Health Reform Prescriptions Offered by President Obama and Congressional Leaders Help Patients?

Health Policy Consensus Group Statement By Thomas P. Miller, Scott Gottlieb, M.D., Robert B. Helms, Joseph Antos, Doug Badger, Robert A. Book, James C. Capretta, Greg D’Angelo, Stephen J. Entin, John C. Goodman, Linda Gorman, John R. Graham, Paul Guppy, John S. Hoff, Merrill Matthews, Amy Menefee, Robert E. Moffit, ...
Commentary

JAMA Wants to Restrict Competition for Pharma Dollars

Many elite, academic doctors would like to believe that they can create a world where human beings do not influence other human beings. This makes them ashamed of their profession’s relationship with research-based drug companies. They believe that any item or communication from a … more »»
Commentary

The “Congressional” Health Care Plan

With the highly publicized White House Forum on Health Reform now in the rearview mirror, President Obama has taken his show on the road. The administration is in the midst of holding five other such forums across the country. These gatherings are intended to set the stage for congressional action ...
Commentary

Leviathan’s Drug Problem: Federal Monopoly of Pharmaceutical Regulation and its Deadly Cost

A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration’s performance and concludes that the agency is overfunded, overstaffed, and denies hundreds of thousands of Americans timely access to new medicines. Leviathan’ s Drug Problem: The Cost of the Federal Monopoly ...
Commentary

FDA is Overfunded, Overstaffed, and Costs Lives According to New Pacific Research Institute Report

FDA is Overfunded, Overstaffed, and Costs Lives According to New Pacific Research Institute Report San Francisco (March 20, 2009) — A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration’s performance and concludes that the agency is overfunded, overstaffed, and denies ...
Scroll to Top